Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

Neurological disorders significantly outnumber diseases in other therapeutic areas. However, developing drugs for central nervous system (CNS) disorders remains the most challenging area in drug discovery, accompanied with the long timelines and high attrition rates. With the rapid growth of biomedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatansever, Sezen, Schlessinger, Avner, Wacker, Daniel, Kaniskan, H. Ümit, Jin, Jian, Zhou, Ming‐Ming, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043990/
https://www.ncbi.nlm.nih.gov/pubmed/33295676
http://dx.doi.org/10.1002/med.21764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043990/
https://www.ncbi.nlm.nih.gov/pubmed/33295676
http://dx.doi.org/10.1002/med.21764

Ejemplares similares